Skip to main content

Veeva Systems guidance

  • VEEV · NYSE
  • Software
  • Health Care Technology
  • S&P 500
$301.53−0.29%Close 13 Nov 2026 · Market value $48.84B · Next results 19 Nov 2026

Veeva Systems gives no forecast in figures in its latest earnings release (6 Nov 2026). Many companies give their outlook on the call only, or none at all.

Read from the company's earnings releases and outlook updates of the last two years. Each forecast is shown with the sentence or table row it was read from; what a release does not state in figures is not shown.

Guidance against results above 8 · within 0 · below 4

The last range given before each period closed, how it moved between releases, and the figure then filed. A measure the company defines itself, or one not comparable with the filed figure, has no verdict.

MeasurePeriodLast guidanceRevisionsDeliveredResult
RevenueFY2027$3.68B to $3.69BRaised twice—To come
EPS · AdjustedFY2027About $9.21Raised twice—To come
Operating income · AdjustedFY2027About $1.64BRaised twice—To come
RevenueQ3 FY2027$932M to $935MGiven once—To come
EPS · AdjustedQ3 FY2027$2.33 to $2.34Given once—To come
Operating income · AdjustedQ3 FY2027$417M to $420MGiven once—To come
RevenueQ2 FY2027$902M to $905MGiven once$928MAbove the range
EPS · AdjustedQ2 FY2027$2.21 to $2.22Given once$1.68Below the range
RevenueQ1 FY2027$855M to $858MGiven once$883MAbove the range
EPS · AdjustedQ1 FY2027$2.13 to $2.14Given once$1.59Below the range
RevenueFY2025$3.17B to $3.17BRaised 4 times$3.20BAbove the range
RevenueQ4 FY2026$807M to $810MGiven once$836MAbove the range
EPS · AdjustedQ4 FY2026About $1.92Given once$1.50Below the range
RevenueQ3 FY2026$790M to $793MGiven once$811MAbove the range
EPS · AdjustedQ3 FY2026$1.94 to $1.95Given once$1.42Below the range
RevenueQ2 FY2026$766M to $769MGiven once$789MAbove the range
RevenueQ1 FY2026$726M to $729MGiven once$759MAbove the range
RevenueQ4 FY2024$696M to $699MGiven once$721MAbove the range

VEEV in the terminal

Guidance said on earnings calls, every revision charted, and guidance set against the analysts' consensus.